MD & A_Q2_63 August 11, 2020 Subject : Management Discussion and Analysis for the second quarter ended 30 June 2020 (reviewed) To : Director and Manager The Stock Exchange of Thailand Ratchthani
loss on temporary investment 8.5 MB. Please be informed accordingly Your Sincerely, (Mr. Nakkil Sung ) Managing Director
informed accordingly Your Sincerely, (Mr. Nakkil Sung) Managing Director
Microsoft Word - MD&A_2022 27 February 2023 Subject: Management Discussion and Analysis Ending 31 December 2022 To: The Managing Director The Stock Exchange of Thailand Unit: MB Summary of operating
-517-0109-14 Fax 66-2-5170529 February 27, 2017 Subject Management Discussion and Analysis for the year ended December 31, 2016 To Managing Director of Stock Exchange of Thailand Table of Financial Ratio
same period at the previous year. Please be informed accordingly. Yours sincerely, Apirak Kanchanakongkha (Mr. Apirak Kanchanakongkha) Assistant Managing Director
. Suphan Sethapanich from as acting as personnel in the capital market business and performing duties as the managing director and the chairman of the Investment Committee for a period of three years and
-5170529 14 November 2017 RE: Explanation of performance for the third quarter of 2017 with a change exceeding twenty percent from the previous year. ATTN: Managing Director, Stock Exchange of Thailand
31st March 2018 To : Managing Director Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at